Insulin resistance in patients with type 1 diabetes;Insulinooporność w cukrzycy typu 1

Pediatric Endocrinology, Diabetes and Metabolism

Volumn 15, Issue 2, 2009, Pages 119-123

  Uruska, Aleksandra ^a   Araszkiewicz, Aleksandra ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Complications; Diabetes mellitus type 1; Insulin resistance; Pathogenesis

Indexed keywords

GLUCOSE; INSULIN;

GLUCOSE TRANSPORT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; SKELETAL MUSCLE; ANIMAL; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GLUCOSE CLAMP TECHNIQUE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; RISK FACTOR;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; RISK FACTORS;

EID: 84883014257     PISSN: 1234625X     EISSN: 20838441     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Shulman G.I.: Cellular mechanisms of insulin resistance. J. Clin. Invest., 2000, 106, 1771-1776.
2. Lillioja S., Mott D.M., Spraul M. i wsp.: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N. Engl. J. Med., 1993, 329, 1988-1992.
3. Perseghin G., Ghosh S., Gerow K., Shulman G.I.: Metabolic defects in lean nondiabetic off - spring of NIDDM parents: a cross-sectional study. Diabetes., 1997, 46, 1001-1009.
4. Kiess W., Böttner A., Raile K. i wsp.: Type 2 diabetes mellitus in children and adolescents: a review from a European perspective. Horm. Res., 2003, 59, supl. 1, 77-84.
5. Ferrannini E., Buzzigoli G., Bonadonna R. i wsp.: Insulin resistance in essential hypertension. N. Engl. J. Med., 1987, 317, 350-357.
6. Laws A., Reaven G.M.: Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J. Intern. Med., 1992, 231, 25-30.
7. Alberti K.G.M.M., Zimmet P., Shaw J.: The metabolic syndrome - a new worldwide definition. Lancet, 2005, 366, 1059-1062.
8. Howard G., O'Leary D.H., Zaccaro D. i wsp.: Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation, 1996, 93, 1809-1817.
9. Savage D.B., Petersen K.F., Shulman G.I. i wsp.: Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension, 2005, 45, 828-833.
10. Feinstein R., Kanety H., Papa M.Z. i wsp.: Tumor necrosis factor-alpha suppresses insulininduced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem., 1993, 268, 26055-26058.
11. Berg A.H., Combs T. P., Scherer P. E.: ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab., 2002, 13, 84-89.
12. Ye J., Kraegen T.: Insulin resistance: central and peripheral mechanisms. Obes. Rev., 2007, 9, 30-34.
13. Yki-Järvinen H., Koivisto V.A.: Natural course of insulin resistance in type I diabetes. N. Engl. J. Med., 1986, 315, 224-230.
14. Williams K.V., Erbey J.R., Becker D. i wsp.: Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes, 2000, 49, 626-632.
15. Pambianco G., Costacou T., Orchard T.J.: The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care, 2007, 30, 1248-1254.
16. Kilpatrick E.S., Rugby A.S., Atkin S.L.: Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes. Diabetes Care, 2007, 30, 707-712.
17. Kibirige M., Metcalf B., Renuka R., Wilkin T.J.: Testing the Accelerator Hypothesis. The relationship between body mass and age at diagnosis of type 1. Diabetes Care, 2003, 26, 2865-2870.
18. Mitchell B.D., Zaccaro D., Wagenknecht L.E. i wsp.: Insulin sensitivity, body fat distribution, and family diabetes history: the IRAS Family Study. Obes. Res., 2004, 12, 831-839.
19. Greenbaum C.J., Cuthbertson D., Krischer J.P.: Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria. Diabetes, 2001, 50, 470-476.
20. Pundziute-Lyckí A., Persson L.A., Cedermark G. i wsp.: Diet, growth, and the risk for type 1 diabetes in childhood: a matched case-referent study. Diabetes Care, 2004, 27, 2784-2789.
21. DeFronzo R.A., Simonson D., Ferrannini E.: Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 1982, 23, 313-319.
22. Lönnroth P., Blohmé G., Lager I. i wsp.: Insulin resistance in fat cells from insulin-treated type I diabetic individuals. Diabetes Care, 1983, 6, 586-590.
23. Baron A.D., Laakso M., Brechtel G. i wsp.: Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J. Clin. Endocrinol. Metab., 1991, 73, 637-643.
24. Kahn B.B., Rosen A.S., Bal J.F. i wsp.: Expression of GLUT1 i GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory eff ects of metabolic factors. J. Clin. Endocrinol. Metab., 1992, 74, 1101-1109.
25. Yki-Järvinen H., Koivisto V.A.: Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. J. Clin. Endocrinol. Metab., 1984, 58, 659-666.
26. Noczyńska A., Filipowski H., Wa̧sikowa R.: Czy nadwaga u pacjentów z cukrzyca̧ typu 1 w okresie dojrzewania jest problemem? Endokr. Diabetol., 2003, 9, 89-92.
27. DeFronzo R.A., Tobin J.D., Andres R.: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol., 1979, 237, E214-223.
28. Wallace T.M., Levy J.C., Matthews D.R.: Use and Abuse of HOMA Modeling. Diabetes Care, 2004, 27, 1487-1495.
29. Stern S.E., Williams K., Ferrannini E. i wsp.: Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements. Diabetes, 2005, 54, 333-339.
30. McLaughlin T., Abbasi F., Cheal K. i wsp.: Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann. Intern. Med., 2003, 139, 802-809.
31. Thorn L.M., Forsblom C., Fagerudd J. i wsp.: Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care, 2005, 28, 2019-2024.
32. Wiegand S., Raile K., Reinehr T. i wsp.: Daily insulin requirement of children and adolescents with type 1 diabetes: eff ect of age, gender, body mass index and mode of therapy. Eur. J. Endocrinol., 2008, 158, 543-549.
33. Balkau B., Tichet J., Caces E. i wsp.: Insulin dose and cardiovascular risk factors in type 1 diabetic children and adolescents. Diabetes Metab., 1998, 24, 143-150.
34. Saraheimo M., Forsblom C., Fagerudd J. i wsp.: Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care, 2005, 28, 1410-1414.
35. Ekstrand A.V., Groop P.H., Gronhagen-Riska C.: Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus. Nephrol. Dial. Transplant., 1998, 13, 3079-3083.
36. Orchard T.J., Olson J.C., Erbey J.R. i wsp.: Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care, 2003, 26, 1374-1379.
37. Koivisto V.A., Stevens L.K., Mattock M. i wsp.: Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care, 1996, 19, 689-697.
38. Yip J., Mattock M.B., Morocutti A. i wsp.: Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet, 1993, 342, 883-887.
39. Martin F.I., Stocks A.E.: Insulin sensitivity and vascular disease in insulin-dependent diabetics. Br. Med. J., 1968, 2, 8.
40. Costacou T., Zgibor J.C., Evans R.W. i wsp.: The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia, 2005, 48, 41-48.